Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1999
11/18/1999WO1999058544A1 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains
11/18/1999WO1999058542A1 Process for the acylation of amino alcohols
11/18/1999WO1999058541A2 Improvements in macrolide production
11/18/1999WO1999058540A2 1-galactose derivatives
11/18/1999WO1999058535A1 Novel cephalosporin compounds, processes for preparation thereof and antimicrobial compositions containing the same
11/18/1999WO1999058534A2 Epothilone derivatives, a method for the production thereof, and their use
11/18/1999WO1999058533A1 Phenylurea and phenylthio urea derivatives
11/18/1999WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058530A1 Water soluble azoles as broad-spectrum antifungals
11/18/1999WO1999058529A1 Water soluble azoles as broad-spectrum antifungals
11/18/1999WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058527A2 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
11/18/1999WO1999058525A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999WO1999058524A1 Benzocarbazole and indenoindole derived estrogenic agents
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058522A1 Naphtho[2,3-b]heteroar-4-yl derivatives
11/18/1999WO1999058521A1 11-aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-benzo[b]naphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058520A1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058519A1 Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058518A2 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058514A1 (2-acylaminothiazole-4-yl)acetic acid derivatives
11/18/1999WO1999058512A1 Morpholino ethers
11/18/1999WO1999058511A1 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/18/1999WO1999058510A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
11/18/1999WO1999058505A2 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
11/18/1999WO1999058504A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament
11/18/1999WO1999058503A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058501A1 Compounds with growth hormone releasing properties
11/18/1999WO1999058499A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors
11/18/1999WO1999058497A1 Substituted guanidines and diaminonitroethenes, their preparation and use
11/18/1999WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058487A1 New compounds, their preparation and use
11/18/1999WO1999058486A1 New compounds, their preparation and use
11/18/1999WO1999058478A1 Novel derivatives of 3,3-diphenylpropylamines
11/18/1999WO1999058168A1 Dextrin-containing composition for preventing surgical adhesions
11/18/1999WO1999058155A1 Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
11/18/1999WO1999058150A1 Preventives/remedies for hepatic cirrhosis
11/18/1999WO1999058142A1 Use of anti-prolactin agents to treat proliferative conditions
11/18/1999WO1999058139A2 Methods for detecting and inhibiting angiogenesis
11/18/1999WO1999058132A1 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis
11/18/1999WO1999058131A1 Use of tetracyclines for treating meibomian gland disease
11/18/1999WO1999058130A1 New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol
11/18/1999WO1999058129A1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
11/18/1999WO1999058128A1 Inhibition of protein kinases with piridinylimidazoles
11/18/1999WO1999058127A1 Novel heterocyclic analogs of diphenylethylene compounds
11/18/1999WO1999058126A1 Use of neomycin for treating angiogenesis-related diseases
11/18/1999WO1999058125A1 Metabolites of ecteinascidin 743
11/18/1999WO1999058124A1 Methods and assays useful in the treatment of alcohol dependence or alcohol abuse
11/18/1999WO1999058123A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis
11/18/1999WO1999058122A1 Novel fatty analogues for the treatment of diabetes
11/18/1999WO1999058121A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
11/18/1999WO1999058120A1 USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
11/18/1999WO1999058119A1 Administration of resveratrol to prevent or treat restenosis following coronary intervention
11/18/1999WO1999058118A2 METHODS FOR REGULATING HEMATOPOIESIS USING CpG-OLIGONUCLEOTIDES
11/18/1999WO1999058117A1 Use of compounds for reducing apoptosis
11/18/1999WO1999058116A2 Novel formulation containing paroxetine
11/18/1999WO1999058115A1 Antidepressant therapy
11/18/1999WO1999058113A2 Novel formulation containing paroxetine
11/18/1999WO1999058110A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
11/18/1999WO1999058104A1 Therapeutic compositions
11/18/1999WO1999058096A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
11/18/1999WO1999058095A2 Pharmaceutical and/or cosmetic compositions containing sea water
11/18/1999WO1999058001A1 Nutritional product for a person having renal failure
11/18/1999WO1999058000A1 Nutritional composition for the treatment of pressure ulcers
11/18/1999WO1999052562A3 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor
11/18/1999WO1999051271A3 Compositions comprising glycol derivatives and alcohols
11/18/1999WO1999051216A3 3-pyridyloxyalkylamine or aryloxyalkylamine derivatives as cholinergic agonists
11/18/1999WO1999051202A3 Quinolone containing liposomes and their use as antibacterial agents
11/18/1999WO1999050285A3 Production methods and uses of a retrovirus
11/18/1999WO1999050269A3 Porphyrins and their use as photosensitizer
11/18/1999WO1999050255A3 Disubstituted pyrazolines and triazolines as factor xa inhibitors
11/18/1999WO1999050239A3 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
11/18/1999WO1999049895A3 Method for increasing the permeability of horny human tissue
11/18/1999WO1999049888A3 Identification of bacterial avirulence genes and their products; vaccines and pharmaceutical compositions containing them
11/18/1999WO1999049856A3 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
11/18/1999WO1999049855A3 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
11/18/1999WO1999049854A3 Use of dexmedetomidine for icu sedation
11/18/1999WO1999047673A3 Isolated mammalian membrane protein genes and related reagents
11/18/1999WO1999047153A3 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY rho GTPase FUNCTION INHIBITORS
11/18/1999WO1999046284A9 Molecules that home to various selected organs or tissues
11/18/1999WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999WO1999045933A9 Novel delivery of hydroxy carboxylic acids
11/18/1999WO1999042134A8 Spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin and a method of making such spray-dried tablettable powders
11/18/1999WO1999042076A9 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/18/1999WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/18/1999DE19821926A1 Use of the known antidepressant mirtazapine
11/18/1999DE19821831A1 Selectively supplementing estrogen deficiency in the central nervous system, using 14,15-cyclopropano estrane steroid compounds
11/18/1999DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999DE19821003A1 New dihydro-indazolone derivatives useful as antiasthmatic, antiallergic and neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999DE19821002A1 New indazole derivatives useful as antiasthmatic, antiallergic, neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999CA2685270A1 Expression vectors for stimulating an immune response and methods of using the same
11/18/1999CA2334830A1 Methods and assays useful in the treatment of alcohol dependence or alcohol abuse
11/18/1999CA2332616A1 Pharmaceutical, hygienic and/or cosmetic compositions containing sea water and their uses
11/18/1999CA2332275A1 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
11/18/1999CA2331962A1 Meiosis regulating compounds
11/18/1999CA2331879A1 Oxyiminoalkanoic acid derivatives
1 ... 6409 6410 6411 6412 6413 6414 6415 6416 6417 6418 6419 6420 6421 6422 6423 6424 6425 6426 6427 6428 6429 ... 7860